Structure

Physi-Chem Properties

Molecular Weight:  956.33
Volume:  894.133
LogP:  1.441
LogD:  0.711
LogS:  -3.732
# Rotatable Bonds:  17
TPSA:  302.19
# H-Bond Aceptor:  21
# H-Bond Donor:  7
# Rings:  12
# Heavy Atoms:  21

MedChem Properties

QED Drug-Likeness Score:  0.102
Synthetic Accessibility Score:  7.872
Fsp3:  0.66
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.654
MDCK Permeability:  7.686950993956998e-05
Pgp-inhibitor:  0.41
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.812
20% Bioavailability (F20%):  0.653
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.15
Plasma Protein Binding (PPB):  44.79497146606445%
Volume Distribution (VD):  0.322
Pgp-substrate:  15.452682495117188%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.998
CYP2C19-inhibitor:  0.007
CYP2C19-substrate:  0.27
CYP2C9-inhibitor:  0.003
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.03
CYP3A4-inhibitor:  0.304
CYP3A4-substrate:  0.256

ADMET: Excretion

Clearance (CL):  1.355
Half-life (T1/2):  0.64

ADMET: Toxicity

hERG Blockers:  0.125
Human Hepatotoxicity (H-HT):  0.143
Drug-inuced Liver Injury (DILI):  0.909
AMES Toxicity:  0.964
Rat Oral Acute Toxicity:  0.84
Maximum Recommended Daily Dose:  0.015
Skin Sensitization:  0.795
Carcinogencity:  0.865
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.924

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469420

Natural Product ID:  NPC469420
Common Name*:   Paeonidanin D
IUPAC Name:   n.a.
Synonyms:   Paeonidanin D
Standard InCHIKey:  QDMFASNVGVOIEZ-ASJHKIPBSA-N
Standard InCHI:  InChI=1S/C47H56O21/c1-42-16-26(49)24-14-46(42,44(24,40(59-3)67-42)20-61-36(57)22-10-6-4-7-11-22)66-39-35(56)33(54)31(52)29(64-39)19-60-41-45(21-62-37(58)23-12-8-5-9-13-23)25-15-47(45,43(2,68-41)17-27(25)50)65-38-34(55)32(53)30(51)28(18-48)63-38/h4-13,24-25,28-35,38-41,48,51-56H,14-21H2,1-3H3/t24-,25-,28-,29-,30-,31-,32+,33+,34-,35-,38+,39+,40+,41+,42+,43+,44+,45+,46-,47-/m1/s1
SMILES:  OC[C@H]1O[C@@H](O[C@]23C[C@H]4[C@@]3(COC(=O)c3ccccc3)[C@H](O[C@@]2(C)CC4=O)OC[C@H]2O[C@@H](O[C@]34C[C@H]5[C@@]4(COC(=O)c4ccccc4)[C@H](O[C@@]3(C)CC5=O)OC)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1078415
PubChem CID:   46883514
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota roots n.a. n.a. PMID[19691309]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT848 Cell Line N9 Homo sapiens Inhibition = 111.5 % PMID[461267]
NPT848 Cell Line N9 Homo sapiens Inhibition = 96.6 % PMID[461267]
NPT848 Cell Line N9 Homo sapiens Inhibition = 83.5 % PMID[461267]
NPT848 Cell Line N9 Homo sapiens Inhibition = 77.1 % PMID[461267]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469420 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9748 High Similarity NPC469421
0.9419 High Similarity NPC469417
0.9236 High Similarity NPC469399
0.9177 High Similarity NPC477623
0.9125 High Similarity NPC150893
0.9125 High Similarity NPC329960
0.9125 High Similarity NPC295408
0.908 High Similarity NPC477471
0.908 High Similarity NPC477473
0.908 High Similarity NPC477466
0.908 High Similarity NPC477469
0.9045 High Similarity NPC34066
0.9045 High Similarity NPC469422
0.9038 High Similarity NPC477905
0.9032 High Similarity NPC469448
0.9018 High Similarity NPC102465
0.8981 High Similarity NPC469477
0.8981 High Similarity NPC133430
0.8924 High Similarity NPC5115
0.8924 High Similarity NPC469398
0.8917 High Similarity NPC472548
0.8862 High Similarity NPC477617
0.8854 High Similarity NPC469415
0.8848 High Similarity NPC469419
0.8839 High Similarity NPC469513
0.8812 High Similarity NPC477735
0.8805 High Similarity NPC472549
0.879 High Similarity NPC222102
0.879 High Similarity NPC303429
0.878 High Similarity NPC477491
0.8758 High Similarity NPC477736
0.875 High Similarity NPC106895
0.8742 High Similarity NPC472030
0.8742 High Similarity NPC242262
0.8742 High Similarity NPC472022
0.8742 High Similarity NPC237549
0.8742 High Similarity NPC257213
0.8742 High Similarity NPC265395
0.8742 High Similarity NPC249471
0.8742 High Similarity NPC473414
0.8742 High Similarity NPC1173
0.8742 High Similarity NPC472005
0.8742 High Similarity NPC256142
0.8742 High Similarity NPC304876
0.8742 High Similarity NPC158333
0.8735 High Similarity NPC477488
0.8688 High Similarity NPC228204
0.8688 High Similarity NPC114410
0.8688 High Similarity NPC26033
0.8688 High Similarity NPC282239
0.8688 High Similarity NPC112523
0.8671 High Similarity NPC7095
0.8659 High Similarity NPC66193
0.8642 High Similarity NPC471102
0.8634 High Similarity NPC217091
0.8625 High Similarity NPC472658
0.8625 High Similarity NPC472657
0.8625 High Similarity NPC69425
0.8625 High Similarity NPC77719
0.8623 High Similarity NPC149002
0.8623 High Similarity NPC469396
0.8623 High Similarity NPC469459
0.8623 High Similarity NPC469458
0.8623 High Similarity NPC88176
0.8608 High Similarity NPC250046
0.8608 High Similarity NPC81698
0.8608 High Similarity NPC60509
0.8606 High Similarity NPC471493
0.8606 High Similarity NPC471134
0.8606 High Similarity NPC477627
0.858 High Similarity NPC469771
0.858 High Similarity NPC472393
0.8571 High Similarity NPC469456
0.8554 High Similarity NPC473468
0.8554 High Similarity NPC61891
0.8554 High Similarity NPC475567
0.8554 High Similarity NPC473557
0.8553 High Similarity NPC198455
0.8553 High Similarity NPC112216
0.8553 High Similarity NPC161239
0.8553 High Similarity NPC165260
0.8535 High Similarity NPC70403
0.8535 High Similarity NPC470159
0.8535 High Similarity NPC158663
0.8535 High Similarity NPC472572
0.8535 High Similarity NPC200471
0.8535 High Similarity NPC476973
0.8535 High Similarity NPC472568
0.8535 High Similarity NPC177940
0.8535 High Similarity NPC184817
0.8535 High Similarity NPC174982
0.8535 High Similarity NPC471104
0.8535 High Similarity NPC29704
0.8535 High Similarity NPC473088
0.8535 High Similarity NPC171525
0.8535 High Similarity NPC472575
0.8535 High Similarity NPC469349
0.8535 High Similarity NPC472571
0.8535 High Similarity NPC470157
0.8535 High Similarity NPC96903
0.8528 High Similarity NPC476784
0.8528 High Similarity NPC477467
0.8516 High Similarity NPC77493
0.8503 High Similarity NPC475531
0.8503 High Similarity NPC475175
0.8503 High Similarity NPC475198
0.85 High Similarity NPC329657
0.85 High Similarity NPC470153
0.85 High Similarity NPC51602
0.85 High Similarity NPC471103
0.8491 Intermediate Similarity NPC471101
0.8491 Intermediate Similarity NPC270590
0.8491 Intermediate Similarity NPC92293
0.8491 Intermediate Similarity NPC301556
0.8491 Intermediate Similarity NPC266265
0.8471 Intermediate Similarity NPC475122
0.8471 Intermediate Similarity NPC472569
0.8471 Intermediate Similarity NPC188865
0.8471 Intermediate Similarity NPC125106
0.8471 Intermediate Similarity NPC11685
0.8471 Intermediate Similarity NPC25768
0.8471 Intermediate Similarity NPC472573
0.8471 Intermediate Similarity NPC70716
0.8471 Intermediate Similarity NPC470152
0.8471 Intermediate Similarity NPC163719
0.8471 Intermediate Similarity NPC95265
0.8471 Intermediate Similarity NPC472570
0.8471 Intermediate Similarity NPC241951
0.8471 Intermediate Similarity NPC95810
0.8471 Intermediate Similarity NPC57628
0.8471 Intermediate Similarity NPC475759
0.8471 Intermediate Similarity NPC476974
0.8466 Intermediate Similarity NPC477470
0.8466 Intermediate Similarity NPC477474
0.8466 Intermediate Similarity NPC477472
0.8457 Intermediate Similarity NPC473670
0.8457 Intermediate Similarity NPC21410
0.8452 Intermediate Similarity NPC40138
0.8439 Intermediate Similarity NPC469418
0.8438 Intermediate Similarity NPC470245
0.8438 Intermediate Similarity NPC473214
0.8438 Intermediate Similarity NPC254558
0.8428 Intermediate Similarity NPC281717
0.8421 Intermediate Similarity NPC148185
0.8418 Intermediate Similarity NPC472556
0.8418 Intermediate Similarity NPC127857
0.8408 Intermediate Similarity NPC163087
0.8391 Intermediate Similarity NPC195114
0.8383 Intermediate Similarity NPC293568
0.8383 Intermediate Similarity NPC117943
0.8375 Intermediate Similarity NPC476975
0.8375 Intermediate Similarity NPC473215
0.8373 Intermediate Similarity NPC477188
0.8373 Intermediate Similarity NPC43304
0.8373 Intermediate Similarity NPC55744
0.8373 Intermediate Similarity NPC477190
0.8373 Intermediate Similarity NPC275477
0.8365 Intermediate Similarity NPC477737
0.8344 Intermediate Similarity NPC475513
0.8344 Intermediate Similarity NPC473755
0.8333 Intermediate Similarity NPC260300
0.8333 Intermediate Similarity NPC80360
0.8323 Intermediate Similarity NPC478073
0.8323 Intermediate Similarity NPC91730
0.8314 Intermediate Similarity NPC13989
0.8313 Intermediate Similarity NPC476077
0.8291 Intermediate Similarity NPC91703
0.8284 Intermediate Similarity NPC120012
0.828 Intermediate Similarity NPC291599
0.828 Intermediate Similarity NPC16912
0.828 Intermediate Similarity NPC118080
0.828 Intermediate Similarity NPC97947
0.828 Intermediate Similarity NPC41481
0.828 Intermediate Similarity NPC472576
0.828 Intermediate Similarity NPC27377
0.828 Intermediate Similarity NPC87448
0.8272 Intermediate Similarity NPC101043
0.8272 Intermediate Similarity NPC197037
0.8272 Intermediate Similarity NPC306799
0.825 Intermediate Similarity NPC474935
0.8242 Intermediate Similarity NPC318447
0.8242 Intermediate Similarity NPC322048
0.8239 Intermediate Similarity NPC111466
0.8239 Intermediate Similarity NPC188217
0.8235 Intermediate Similarity NPC265600
0.8232 Intermediate Similarity NPC473611
0.8232 Intermediate Similarity NPC469730
0.8232 Intermediate Similarity NPC132599
0.8232 Intermediate Similarity NPC473632
0.8217 Intermediate Similarity NPC473060
0.8217 Intermediate Similarity NPC473085
0.8217 Intermediate Similarity NPC4341
0.8217 Intermediate Similarity NPC275592
0.8217 Intermediate Similarity NPC473112
0.8217 Intermediate Similarity NPC200592
0.8217 Intermediate Similarity NPC147880
0.8217 Intermediate Similarity NPC97667
0.8217 Intermediate Similarity NPC473109
0.8217 Intermediate Similarity NPC477904
0.8217 Intermediate Similarity NPC43241

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469420 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8246 Intermediate Similarity NPD7799 Discontinued
0.7921 Intermediate Similarity NPD8407 Phase 2
0.7853 Intermediate Similarity NPD8368 Discontinued
0.7765 Intermediate Similarity NPD8312 Approved
0.7765 Intermediate Similarity NPD8313 Approved
0.7684 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.765 Intermediate Similarity NPD8435 Approved
0.765 Intermediate Similarity NPD8360 Approved
0.765 Intermediate Similarity NPD8361 Approved
0.7637 Intermediate Similarity NPD8434 Phase 2
0.7566 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7236 Approved
0.75 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD7228 Approved
0.7421 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD7239 Suspended
0.7409 Intermediate Similarity NPD8320 Phase 1
0.7409 Intermediate Similarity NPD8319 Approved
0.7407 Intermediate Similarity NPD8485 Approved
0.7368 Intermediate Similarity NPD7699 Phase 2
0.7368 Intermediate Similarity NPD7700 Phase 2
0.7363 Intermediate Similarity NPD7240 Approved
0.7351 Intermediate Similarity NPD8150 Discontinued
0.7299 Intermediate Similarity NPD8455 Phase 2
0.7267 Intermediate Similarity NPD7458 Discontinued
0.7211 Intermediate Similarity NPD6535 Approved
0.7211 Intermediate Similarity NPD6534 Approved
0.7198 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7435 Discontinued
0.7174 Intermediate Similarity NPD7685 Pre-registration
0.7172 Intermediate Similarity NPD8151 Discontinued
0.7158 Intermediate Similarity NPD7074 Phase 3
0.7158 Intermediate Similarity NPD7472 Approved
0.7135 Intermediate Similarity NPD7808 Phase 3
0.7135 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD4965 Approved
0.7119 Intermediate Similarity NPD4967 Phase 2
0.7119 Intermediate Similarity NPD4966 Approved
0.7104 Intermediate Similarity NPD7054 Approved
0.7092 Intermediate Similarity NPD7698 Approved
0.7092 Intermediate Similarity NPD7697 Approved
0.7092 Intermediate Similarity NPD7696 Phase 3
0.7081 Intermediate Similarity NPD7251 Discontinued
0.7079 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD7874 Approved
0.705 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD3818 Discontinued
0.7039 Intermediate Similarity NPD6234 Discontinued
0.7035 Intermediate Similarity NPD7701 Phase 2
0.7027 Intermediate Similarity NPD6797 Phase 2
0.7026 Intermediate Similarity NPD6782 Approved
0.7026 Intermediate Similarity NPD6780 Approved
0.7026 Intermediate Similarity NPD6781 Approved
0.7026 Intermediate Similarity NPD6779 Approved
0.7026 Intermediate Similarity NPD6778 Approved
0.7026 Intermediate Similarity NPD6776 Approved
0.7026 Intermediate Similarity NPD6777 Approved
0.7022 Intermediate Similarity NPD7058 Phase 2
0.7022 Intermediate Similarity NPD7057 Phase 3
0.6989 Remote Similarity NPD6559 Discontinued
0.698 Remote Similarity NPD8462 Phase 1
0.6979 Remote Similarity NPD6213 Phase 3
0.6979 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6979 Remote Similarity NPD6212 Phase 3
0.697 Remote Similarity NPD7870 Phase 2
0.697 Remote Similarity NPD7871 Phase 2
0.6949 Remote Similarity NPD37 Approved
0.6935 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6931 Remote Similarity NPD7801 Approved
0.6923 Remote Similarity NPD7266 Discontinued
0.691 Remote Similarity NPD7819 Suspended
0.6901 Remote Similarity NPD8166 Discontinued
0.6901 Remote Similarity NPD4628 Phase 3
0.6899 Remote Similarity NPD5125 Phase 3
0.6899 Remote Similarity NPD5126 Approved
0.6869 Remote Similarity NPD6823 Phase 2
0.6868 Remote Similarity NPD8127 Discontinued
0.6862 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6855 Remote Similarity NPD8328 Phase 3
0.6847 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6847 Remote Similarity NPD7783 Phase 2
0.6845 Remote Similarity NPD8404 Phase 2
0.6836 Remote Similarity NPD4380 Phase 2
0.6831 Remote Similarity NPD3787 Discontinued
0.6816 Remote Similarity NPD5760 Phase 2
0.6816 Remote Similarity NPD5761 Phase 2
0.6816 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6813 Remote Similarity NPD5494 Approved
0.6811 Remote Similarity NPD7473 Discontinued
0.6807 Remote Similarity NPD7961 Discontinued
0.6796 Remote Similarity NPD7075 Discontinued
0.6788 Remote Similarity NPD7008 Discontinued
0.6782 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6776 Remote Similarity NPD7199 Phase 2
0.6774 Remote Similarity NPD3751 Discontinued
0.6761 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6166 Phase 2
0.6757 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6168 Clinical (unspecified phase)
0.675 Remote Similarity NPD7680 Approved
0.674 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6738 Remote Similarity NPD5844 Phase 1
0.673 Remote Similarity NPD8516 Approved
0.673 Remote Similarity NPD8513 Phase 3
0.673 Remote Similarity NPD8515 Approved
0.673 Remote Similarity NPD8517 Approved
0.6717 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6714 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6705 Remote Similarity NPD6273 Approved
0.6685 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6685 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6959 Discontinued
0.6683 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7497 Discontinued
0.6667 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6190 Approved
0.6649 Remote Similarity NPD6232 Discontinued
0.6648 Remote Similarity NPD6599 Discontinued
0.6648 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6647 Remote Similarity NPD3764 Approved
0.6646 Remote Similarity NPD7319 Approved
0.6628 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6613 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6611 Remote Similarity NPD7411 Suspended
0.6601 Remote Similarity NPD7999 Approved
0.6592 Remote Similarity NPD3226 Approved
0.6587 Remote Similarity NPD7930 Approved
0.6575 Remote Similarity NPD6801 Discontinued
0.6564 Remote Similarity NPD7507 Approved
0.655 Remote Similarity NPD7097 Phase 1
0.6545 Remote Similarity NPD6764 Approved
0.6545 Remote Similarity NPD6765 Approved
0.6538 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6532 Remote Similarity NPD2346 Discontinued
0.6522 Remote Similarity NPD3749 Approved
0.6519 Remote Similarity NPD2629 Approved
0.6514 Remote Similarity NPD7003 Approved
0.6503 Remote Similarity NPD5402 Approved
0.6503 Remote Similarity NPD3817 Phase 2
0.6495 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6485 Remote Similarity NPD7736 Approved
0.6484 Remote Similarity NPD1934 Approved
0.6481 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6481 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6481 Remote Similarity NPD8059 Phase 3
0.6478 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6478 Remote Similarity NPD4198 Discontinued
0.6474 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6467 Remote Similarity NPD7768 Phase 2
0.6464 Remote Similarity NPD7028 Phase 2
0.6461 Remote Similarity NPD2533 Approved
0.6461 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6461 Remote Similarity NPD2532 Approved
0.6461 Remote Similarity NPD2534 Approved
0.646 Remote Similarity NPD7741 Discontinued
0.6457 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6442 Remote Similarity NPD7457 Clinical (unspecified phase)
0.642 Remote Similarity NPD8033 Approved
0.6415 Remote Similarity NPD5951 Approved
0.641 Remote Similarity NPD6785 Approved
0.641 Remote Similarity NPD6784 Approved
0.6409 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6404 Remote Similarity NPD6799 Approved
0.6389 Remote Similarity NPD5403 Approved
0.6386 Remote Similarity NPD8285 Discontinued
0.6379 Remote Similarity NPD5406 Approved
0.6379 Remote Similarity NPD5404 Approved
0.6379 Remote Similarity NPD5405 Approved
0.6379 Remote Similarity NPD5408 Approved
0.6378 Remote Similarity NPD3882 Suspended
0.6369 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6369 Remote Similarity NPD5401 Approved
0.6364 Remote Similarity NPD6674 Discontinued
0.6359 Remote Similarity NPD1465 Phase 2
0.6358 Remote Similarity NPD8377 Approved
0.6358 Remote Similarity NPD8294 Approved
0.6322 Remote Similarity NPD2799 Discontinued
0.6319 Remote Similarity NPD8380 Approved
0.6319 Remote Similarity NPD8378 Approved
0.6319 Remote Similarity NPD8379 Approved
0.6319 Remote Similarity NPD8296 Approved
0.6319 Remote Similarity NPD8335 Approved
0.6313 Remote Similarity NPD7390 Discontinued
0.6296 Remote Similarity NPD7610 Discontinued
0.6289 Remote Similarity NPD8133 Approved
0.6282 Remote Similarity NPD6686 Approved
0.628 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6276 Remote Similarity NPD7090 Clinical (unspecified phase)
0.627 Remote Similarity NPD2801 Approved
0.6257 Remote Similarity NPD2313 Discontinued
0.625 Remote Similarity NPD2343 Clinical (unspecified phase)
0.625 Remote Similarity NPD6010 Discontinued
0.625 Remote Similarity NPD7584 Approved
0.6243 Remote Similarity NPD230 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data